A Special Report on Gene Therapy
This special report on Gene Therapy Companies by K.K. Jain provides an up-to-date overview of the gene therapy industry. It contains a wealth of very practical information on 105 companies. For each company, information is available on the people to contact, their contact details, a corporate history, the company's technologies and products, financial data, patents held, products in clinical trials, collaborations with other companies and selected publications from the company's scientists. Almost 200 companies were initially considered for inclusion but just over 100 companies were finally selected as they fulfilled the necessary criteria to be classified as a 'Gene Therapy Company,', defined broadly to include cell therapy companies. Not all of the companies devote their activity exclusively to gene therapy but they have sufficient relevance to be included. As part of this project, new companies were discovered that have not been reported in other publications or on the internet. Dr. Jain has spared no effort to ensure that the information is up-to-date and accurate at the time of publishing. In most instances, the information was reviewed by the companies to correct any outdated information or to add any complementary or recent information. In addition to the detailed descriptions of each company, the data is also presented in summary tabular form so that at a glance the reader can identify collaborations within the gene therapy industry, or determine which companies are pursuing strategies involving viral, non-viral or other approaches to gene therapy, and which diseases are being targetted. Given that much of the gene therapy research and development is currently being carried out within the industrial sector, it is important for scientists, managers and investors to have the relevant information at their fingertips. This special report provides that information in one accurate, easy to consult and up-to-date source.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Basics of genetherapy
Different strategies for genetherapy
Classification of genetherapy companies
Profiles of genetherapy companies
Genzyme Molecular Oncology
Hoffman La Roche
Human GenOme Sciences
Boston Scientific Corporation
Gene Therapy Systems
Stem Cell Sciences
Weighted scale for evaluating genetherapy technologies
AAV vectors activity adeno-associated adenoviral adenoviral vectors agreement angiogenesis animal antibody antigen applications Ariad biological biotechnology Biovector blood bone marrow cancer cells cancer vaccine cardiovascular disease Cell Genesys cell lines cell therapy cellular chimeraplasty chromosomes clinical trials collaboration combination company's Corporate Overview cystic fibrosis deliver delivery system Dendreon dendritic cells develop and commercialize discovery disorders drug E-mail electroporation etal gene delivery gene expression gene therapy products gene transfer gene-based genetherapy genetransfer genomics Genovo Genzyme hemophilia human immune response injection Institute Introgen lipid liposomes manufacturing melanoma methods million Molecular molecules Nexel nonviral novel Oxford BioMedica patent pharmaceutical Phase I/II plasmid potential President and CEO proprietary prostate cancer receptor recombinant replication ribozymes Schering-Plough Selected Publications Selective Genetics small-molecule specific stem cells target cells telomerase therapeutic genes therapeutic proteins tissue transfection Transgene transplantation treatment tumor cells University Valentis vascular Vical viral vectors virus